Pharmacie du Centre Ville SRL
Pharmacie du Centre Ville reported total assets of 184,866 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Pharmacie du Centre Ville shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets +90 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie du Centre Ville's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 05 Oct 2025
- Year ended 31 Dec 2023filed on 11 Nov 2024
- Year ended 31 Dec 2022filed on 05 Apr 2024
- Year ended 31 Dec 2021filed on 17 Nov 2022
Pharmacie du Centre Ville's financial analysis
- Solvency9.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie du Centre Ville
Pharmacie du Centre Ville's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0695.844.445
- VAT number
- BE0695844445
- Peppol
- Registered · 0208:0695844445 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 May 2018
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie du Centre Ville (SRL) has been based in Brussels since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 10,148 € and equity of 17,517 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie du Centre Ville
Companies in the same business, of comparable size and area, outside its group.
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
- Emilie Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,476 €
- Apotheek Slabbinck Retail sale of pharmaceutical products Blankenberge · balance sheet 181,970 €
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- Hilde Braeken Retail sale of pharmaceutical products Hasselt · balance sheet 180,493 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
- Ilse Verstraeten Retail sale of pharmaceutical products Sint-Truiden · balance sheet 178,548 €
Frequently asked questions about Pharmacie du Centre Ville
What is the revenue of Pharmacie du Centre Ville?
Pharmacie du Centre Ville files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie du Centre Ville?
In Belgium, the VAT number is the company number prefixed with BE: BE0695844445 for Pharmacie du Centre Ville, if the company is VAT-registered. Its company number (CBE) is 0695.844.445.
Where is the registered office of Pharmacie du Centre Ville?
According to the CBE register, the registered office of Pharmacie du Centre Ville is in 1000 Brussels.
What is the equity of Pharmacie du Centre Ville?
At the close of the 2025 financial year, the equity of Pharmacie du Centre Ville amounts to 17,517 €, a solvency of 9.5% of total assets.
Who manages Pharmacie du Centre Ville?
The register lists 1 active mandates at Pharmacie du Centre Ville. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie du Centre Ville
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →